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1. Introduction 
This work is part of a general study on snake 
neurotoxins. In previous papers [1,2], we had shown 
that the application to snake venoms of the general 
method of purification which was developed to 
isolate toxins from scorpion venoms [3-7] was very 
efficient. Four neurotoxins from two different 
sources ofNaja haje venom [1] and two neuroto- 
xins fromNaja nigricollis venom [2] were purified 
when only one toxin had been previously isolated 
in a pure form from each of these venoms by others 
[8,9]. N-terminal sequences determination using 
automatic Edman degradation, was found to be the 
best method for rapid characterization f newly pu- 
rified toxins [2]. We report, in this paper, on the 
application of these methods to the venom of Naja 
nigricollis mossambica Peters. The partial sequences 
of the neurotoxins show that these are more closely 
related to cobrotoxin (a toxin isolated from the venom 
of the formosan Elapidae Naja naja atra) than the 
toxins I and II isolated from the venom ofNaja nigri- 
collis living in Ethiopia [2]. The taxonomical im- 
portance of these results is discussed. 
2. Experimental 
2.1. Purification of  the toxins 
The venom (30 g) was obtained from D. Muller 
(Johannesburg, South-Africa). The crude venom, 
first dissolved in a 0.1 M ammonium acetate buffer 
(pH 8.5), was applied on Sephadex G-50 gel equili- 
brated in the same buffer. The gel filtration was per- 
formed using recycling (3 cycles) through four 1 
meter columns of gel. The neurotoxic fraction was 
freeze dried and applied, for ion exchange chroma- 
tography, on a Bio-Rex 70 column equilibrated in 
a 0.2 M ammonium acetate buffer at pH 7.30. The 
elution with the same buffer led to the final purifi- 
cation of toxin I and toxin II. A linear gradient (from 
0.2 M to 2 M ammonium acetate, pH 7.30) was then 
applied at the top of the column, eluting toxic frac- 
tion III. This fraction gave finally toxin III by equili- 
brium chromatography on Bio-Rex 70 (0.5 M ammo- 
nium acetate buffer, pH 7.30). 
Qualitative and quantitative toxicity measurements 
were carried out, according to Behrens and Karber 
[10], using C3H/He mice of 20 +- 3 g (C.S.E.A.L. - 
C.N.R.S., Orl6ans-la-Source, France) as previously 
described [5,7]. 
2.2.. Preparation of  reduced and S-methylated toxins 
Preparation of reduced and S-methylated toxins (RM- 
toxins) was performed as previously described [11]. 
2.3. Amino acid analysis 
Samples of native or RM-toxins were hydrolysed 
in 6 N HC1 for 20 hr and 70 hr at 110°C in sealed 
evacuated tubes. For the determination f tryptophan, 
the hydrolyses were made in 0.3 M p-toluenesulfonic 
acid solution containing 0.2% of tryptamine [12]. 
The hydrolysates were analysed on a Spinco Auto- 
matic Amino Analyzer model 120 C. 
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Table 1 
Purification of Nafa nigricollis mossambica toxins 
Purification step Toxic fraction Reference to Yield in toxicity Specific toxicity 
fig. l from crude venom % 
Crude venom 100 19 
Gel filtration with recycling on R A 80 473 
Sephadex G-50 
I on then linear gradient to II B 3.8 76.3 869 
Bio-Rex 70 AcNH 4 2 M pH 7.30 I: III 12.2 520 
Chromatography on Bio-Rex 70 T III C 12.1 526 
AcNH 4 0.5 M pH 7.30 
The specific toxicity was arbitrarily defined as the number of LDso per A2~ o unit. 
2.4. Edman degradation 
Automat ic  sequencing was per formed on 0.4 
/amole of  RM-toxins using a Protein Sequencer 
PS 100 (Socosi, 94100-Saint-Maur,  France)  and 
procedures described earlier [2] .  
2.5. Carboxypeptidase digestion 
The RM-toxins were dissolved (1%, w/v) in 0.4 M 
dimethyla l ly lamine-tr i f luoroacet ic  acid buffer,  pH 
8.0. Carboxypept idase A (d i isopropylphosphof luor i -  
date treated, Worth ington)  was used in an enzyme to 
substrate ratio of  2 :100 (w/w).  The digestion was 
carried out  in a glass s toppered vial at 35°C. Al iquots 
of the solut ion (0.05 ml) were removed at various 
intervals (1, 5, 15, 30, 60, 180, 360 min),  acidif ied 
wi th  an equal volume of  pure acetic acid, freeze 
dried and subjected to amino acid analysis. 
3. Results 
Table 1 summarises the data obta ined concerning 
the pur i f icat ion of  the three neurotox ins  ofNaja ni- 
gricollis mossambica. Al though a th i rd step was ne- 
cessary to f inally purify tox in  II1, the two first steps 
were suff ic ient to obta in  in a pure form toxins I 
and 1I. The f inal yield in toxic i ty  was 76.2% f rom 
the crude venom. Fig. 1 shows the ehi t ion patterns 
corresponding to the di f ferent chromatographic  
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Fig. 1. Purification ofNaja nigricollis mossambica neurotoxins. 
(A) Gel filtration with recycling on Sephadex G-50 of 6 g of 
venom. Four columns of 3.2 × 100 cm; 0.1 M ammonium 
acetate buffer pH 8.5; flow rate, 77 ml/hr. Fractions indica- 
ted by the full line are collected. Only the material marked 
by the dotted line is recycled. Vertical arrows indicate start 
of the 3 consectutive cyclcs. R = toxic fractions; Ph = phos- 
pholipase activity. (B) Chromatoffaphy on Bio-Rex 70 of 
fractions R obtained from 6 g of venom. 4 × 50 cm column; 
0.2 M ammonium acetate buffer pH 7.30; vertical arrow in- 
dicates the start of the elution with a linear gradient of am- 
monium acetate buffer from 0.2 M pH 7.30 to 2 M pH 7.30 
in a total volume of 1.24 litres; flow rate, 50 ml/hr. Double 
beaded arrows indicate pooling of toxic fractions: T I 
(toxin I), T II (toxin II) and F III (toxic fraction liD. (C) 
Chromatography on Bio-Rex 70 of fraction F III corres- 
ponding to 18 g of venom. 2 × 50 cm column; 0.5 M 
ammonium acetate buffer pH 7.30; flow rate 10 ml/hr. 
Double headed arrow indicates pooling of toxic fractions 
(T III = toxin III). 
336 
Volume 42, number 3 
Material 
FEBS LETTERS 
Table 2 
Weight of the LDs0 and purification yields 
Weight of the LDs0 for Coefficient of toxicity 
the 20 g mouse enhancement from 
crude venom 
(#g) (fold) 
Yields of toxins 
from crude venom 
(~ w/w) 
Crude venom 40 - - 
Toxin I 0.80 50 1.17 
Toxin II 0.77 52 0.07 
Toxin III 1.01 40 0.38 
June1974 
Table 3 
Amino-acid compositions of Naja nigricollis mossambica toxins 
Amino acid Toxin I Toxin II Toxin llI 
Tryptophan * 1.10 (1) 1.10 (1) 1.99 (2) 
Lysine 4.05 (4) 4.04 (4) 4.92 (5) 
Histidine 2.00 (2) 2.93 (3) 2.82 (3) 
Arginine 7.01 (7) 6.21 (6) 5.96 (6) 
Aspartic acid 7.11 (7) 8.10 (8) 8.19 (8) 
Threonine 7.86 (8) 8.10 (8) 6.72 (7) 
Serine 2.95 (3) 3.90 (4) 2.93 (3) 
Glutamic acid 7.01 (7) 6.27 (6) 5.13 (5) 
Proline 3.75 (4) 3.67 (4) 3.96 (4) 
Glycine 5.92 (6) 5.09 (5) 3.97 (4) 
Alanine - (0) - (0) 1.05(1) 
Half-cystine * 7.33 (8) 7.26 (8) 7.21 (8) 
Valine 1.05 (1) 1.02 (1) 1.10 (1) 
Methionine - (0) - (0) 1.00 (1) 
Isoleucine 0.98 (1) 0.98 (1) 1.08 (1) 
Leucine 2.03 (2) 1.86 (2) 1.96 (2) 
Tyrosine 1.99 (2) 1.90 (2) 2.00 (2) 
Phenylalanine - (0) - (0) - (0) 
Total 63 63 63 
Molecular weight 7176.2 7173.1 7315.4 
1% 
A 1 em at 280 nm 13.70 14.46 21.48 
10 -3 ×e (max) ** 9.80 10.37 15.70 
(280 rim) (280 nm) (280 nm) 
* Half-cystine and tryptophan residues were quantified after 
p - toluene - sulfonic acid hydrolysis 
** M -1 X cm - t  . 
steps. Table 2 gives the purif ication yields and the 
weight of  the three toxins corresponding to their 
IDso~for the 20 g mouse. 
The amino acid composit ions of  the three toxins 
are given in table 3 together with their molecular 
weights and their molecular ext inct ion coefficients 
at 280 nm. The N-terminal and C-terminal sequences, 
as they were determined by Edman automatic sequen- 
cing and carboxypeptidase A hydrolysis on reduced 
and methylated toxins, are given in fig. 2 and com- 
pared to the sequences ofNaja naja atra cobrotoxin 
[13] andNaja nigricollis toxins I and I1 [2,14]. 
4. Discussion 
In the case of  Naja nigricollis mossambica venom 
it has been possible to shorten the general method of 
purif ication used in our laboratory [1, 2, 7]. The 
first two steps: extract ion by water and dialysis, found 
to be absolutely necessary for the purif ication of  
scorpion venoms [15],  could be avoided and the 
venom dissolved in an ammonium acetate buffer was 
applied straight on a gel f i ltration column for recy- 
cling. Contrary to what we observed with scorpion 
toxins (unpublished results) Bio-Rex 70 was found 
to be more suitable than Amberl ite CG-50 as it was 
noticed for other snake toxins [16]. Fraction III 
which was eluted using an ionic strength linear gra- 
dient had to be finally purif ied by equil ibrium chro- 
matography which, obviously, gives a better resolu- 
t ion for proteins having very similar pHi. It is the 
first toxin for which we found necessary to use a 
gradient. This can be due to its relatively high con- 
tent in tryptophan added to its strong basicity. The 
three purified toxins account all together for 76.2% 
of the toxic i ty of  the venom. As 20% of the venom 
toxicity,  corresponding to the phospholipase activity, 
was recovered in the second protein fraction eluted 
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10 2O 3O 
T I H -Leu-G•u-Cys -H is -Asn-G•n-G•n-Ser -Ser -G•u-Pr• -P r• -Thr -Thr -Thr -Arg -•ys -Ser -G•y-G•y-G•u-Thr -Asn-•ys -Tyr -Lys -Lys -Arg -Trp -Arg -  
I0 20 30 
T II H -Leu-Asp-Cys -H is -Asn-G•n-G•n-Ser -Ser -G•u-Pr• -P r• -Thr -Thr -Thr -Arg -Cys -•er -Arg -G•y-G•u-Thr -Asn-•ys -Tyr -Lys -Lys -Arg -Trp -Arg -  
10 20 30 
T III H-Leu-Asn-Cys-His-Asn-G•n-Met-•er-A•a-G•n-Pr•-Pr•-Thr-Thr-Thr-Arg-Cys-Ser-Arg-Trp-G1u-Thr-Asn-Cys-Tyr-Lys-Lys-Arg-Trp-Arg- 
10 20 30 
C H-Leu-G•u-Cys-His-Asn-G•n-G•n-•er-Ser-G•n-Thr-Pr•-Thr-Thr-Thr-G•y-Cys-Ser-G•y-G•y-G•u-Thr-Asn-Cys-Tyr-Lys-Lys-Arg-Trp-Arg-  
I0 20 
Nn I H -Leu-G•u-Cys -H is -Asn-G•n-G•n-Ser -•er -G•n-Pr• -P•• -Thr -Thr -Lys -Thr -•ys -P r• - - -G•y-G•u-Thr -Asn-Cys -Tyr -Lys -Lys -Va•-Trp -Arg -  
10 20 
Nn II H -Met - I1e -Cys -H is -Asn-G1n-G1n-Ser -Ser -G1n-Pr• -P r• -Thr -Thr -Lys -Thr -Cys -Pr• - - -G•y-G1u-Thr -Asn-Cys -Tyr -Lys -Lys -Va•-Trp -Arg -  
4 0 63 
T I Asp -H is -Arg -G ly -Tyr -Arg -Thr -G lu -Arg -G ly -Cys -G ly -  X -P ro -Thr -Va l -  . . . . . . . . . . . . . . . . . .  -Cys -Asn-Asn-OH 
63 
T II Asp-  X - X -G ly -Tyr -  X -Thr-  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -Cys -Asn-Asn-OH 
40 63 
T III Asp -H is -Arg -G ly -Tyr -Lys -Thr -G lu -Arg -G ly -Cys -G ly -Cys -  X - X -Val -  . . . . . . . . . . . . . . . . . .  -Cys -Asn-Asn-OH 
40 62 
C Asp-H is -Arg -G ly -Tyr -Arg -Thr -G lu -Arg -G ly -Cys -G ly -Cys -Pro -Ser -Va l -  • . . . . . . . . . . . . . . . . .  -Cys -Asn-Asn-OH 
30 40 61 
Nn I Asp -H is -Arg -G ly -Thr - l l e - l l e -G lu -Arg -G ly -Cys -G ly -Cys -Pro -Thr -Va l -  • . . . . . . . . . . . . . . . . .  -Cys -Asn-Asn-OH 
30 61 
Nn II Asp -H is -Arg -G ly -Thr - l l e - l l e - .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  -Cys -Asn-Asn-OH 
Fig. 2. N- and C-terminal sequences ofNaja nigricollis mossambica neurotoxins (T I, T II and T III). C: cobrotoxin; Nn 1 and 
Nn lh toxins I and I1 ofNaja nigricollis. X: not determined. : deletion. 
from Sephadex G-50 (see fig. 1.A), one can assume 
that the yield of neurotoxicity (95% from the crude 
venom) is excellent. 
Elapidae and Hydrophidae snake neurotoxins may 
be divided into two groups according to the number 
of constitutive amino acids [1]. The first group con- 
sisted of the so called 'short' toxins (60-62  residues) 
[17]. The three toxins of Naja nigricollis mossambica 
belong obviously to this first group although they are 
made of 63 amino acid residues. As the three 'short' 
toxins account for 95% of neurotoxicity, one can 
assume that this venom does not contain toxin be- 
longing to the second group consisted of the so called 
'long' toxins (71-74  residues). Toxin III is the first 
newly discovered 'short' toxin containing two tryp- 
tophan residues and one alanine residue; in addition 
the only methionine residue is not at the N-terminal 
position as found until now for 'short' toxins contain- 
ing methionine. In the second position from the 
N-terminal end, Glu, Asp and Asn residues have been 
found respectively in toxins I, II and III where gener- 
ally Glu is present. In the positions 19 and 20 the 
sequence -G ly  G ly -  found in toxin I, just as in co- 
338 
brotoxin, is replaced by the sequences -Arg -G ly -  
(toxin II) or -Arg -Trp -  (toxin II). This is of inter- 
est as Gly 20 was till now considered to be an invari- 
ant residue not only in 'short' and 'long' toxins [i 7] 
but also in cytotoxins [18,19]. 
If Gln was found in position 10 in toxin I l l  as in 
all other 'short'toxins but Dendroaspis polylepis 
toxin a [17], a Glu res{due was shown to exist in this 
position in the toxins I and II. 
According to amino acid sequence the three toxins 
of Naja nigricollis mossambica are more similar to 
cobrotoxin from Naja naja atra [13] than to the 
toxins 1 and II ofNaja nigricollis [2,14]. Conside- 
ring the amino acid compositions of cobrotoxin [13] 
and of Naja nigricollis mossambica toxins 1, II and 
II1 (table 3), as also the available sequence data 
(fig. 2), one can assume that the sequences still re- 
maining to be determined, will be very close to that 
of cobrotoxin. These results may show to be of some 
taxonomical importance as it has been found that 
Naja nigricollis toxin I and II show amino acid se- 
quences very close to those of toxins I and II of 
Naja haje [2]. However the obvious problem of the 
Volume 42, number 3 FEBS LETTERS June 1974 
authenticity of the starting material exists (for example 
in our case the presence of toxin II in a very low a- 
mount might well be taken as one indication of con- 
tamination i spite of the real competence of the 
snake catcher): the venom of Naja haje and Naja ni- 
gricollis were both from Ethiopia [2] whereas Naja 
naja atra and Naja nigricollis mossambica venoms 
were collected respectively in China and in South- 
Africa which made impossible, in that case, any pos- 
sible confusion. For these reasons, the rapid charac- 
terization of the proteins isolated from snake venoms 
has to be taken as a very important problem which 
must be urgently solved. The way we choose does not 
use a big amount of protein and is not time consuming 
like the determination f a complete amino acid se- 
quence which is, till now, the best chemical test. As 
a matter of fact it will allow a quite better classifica- 
tion than to take into consideration the antigenic 
characteristics of these molecules [20]. Moreover, 
using such chemical criteria, people would never have 
published hypothesis based on pharmacological nd 
immunological results [21-23] obtained with a ve- 
nom which as obviously [2] a mixture of Echis cari- 
natus ( Viperidae) and Na]a nigricollis ( Elapidae) 
venoms. 
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